{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T08:49:04Z","timestamp":1782031744126,"version":"3.54.5"},"reference-count":127,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,3]],"date-time":"2027-03-03T00:00:00Z","timestamp":1804032000000},"content-version":"am","delay-in-days":336,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.bbcan.2026.189567","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T15:52:27Z","timestamp":1772207547000},"page":"189567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cutting to the core: Proteases in the tumor\u2013bone interface and metastatic progression"],"prefix":"10.1016","volume":"1881","author":[{"given":"Ridhi","family":"Bhola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reegan","family":"Sturgeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbcan.2026.189567_bb0005","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189567_bb0010","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3390\/cells11030388","article-title":"Breast cancer bone metastasis: a narrative review of emerging targeted drug delivery systems","volume":"11","author":"Shao","year":"2022","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189567_bb0015","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3390\/cancers17020218","article-title":"Incidence and prevalence of bone metastases in different solid tumors determined by natural language processing of CT reports","volume":"17","author":"Long","year":"2025","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189567_bb0020","first-page":"24","article-title":"Bone metastasis: concise overview","volume":"32","author":"Chin","year":"2015","journal-title":"Fed. Pract."},{"key":"10.1016\/j.bbcan.2026.189567_bb0025","doi-asserted-by":"crossref","first-page":"1105745","DOI":"10.3389\/fonc.2022.1105745","article-title":"Research progress of bone metastases: from disease recognition to clinical practice","volume":"12","author":"Yang","year":"2023","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189567_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/osteology1010002","article-title":"The role of cathepsins in the growth of primary and secondary neoplasia in the bone","volume":"1","author":"Fasanya","year":"2020","journal-title":"Osteology"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189567_bb0035","first-page":"907","article-title":"Osteomimicry: how tumor cells try to deceive the bone","volume":"2","author":"Rucci","year":"2010","journal-title":"Front. Biosci. (Schol. Ed.)"},{"key":"10.1016\/j.bbcan.2026.189567_bb0040","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.breast.2016.09.017","article-title":"Breast cancer osteomimicry and its role in bone specific metastasis; an integrative, systematic review of preclinical evidence","volume":"30","author":"Awolaran","year":"2016","journal-title":"Breast"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189567_bb0045","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189567_bb0050","article-title":"Bone metastases: an overview","volume":"11","author":"Macedo","year":"2017","journal-title":"Oncol. Rev."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189567_bb0055","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1158\/1535-7163.MCT-07-0234","article-title":"Molecular biology of bone metastasis","volume":"6","author":"Kingsley","year":"2007","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189567_bb0060","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41413-020-00105-1","article-title":"Molecular mechanisms and clinical management of cancer bone metastasis","volume":"8","author":"Wang","year":"2020","journal-title":"Bone Res."},{"issue":"D1","key":"10.1016\/j.bbcan.2026.189567_bb0065","doi-asserted-by":"crossref","first-page":"D503","DOI":"10.1093\/nar\/gkt953","article-title":"MEROPS: the database of proteolytic enzymes, their substrates and inhibitors","volume":"42","author":"Rawlings","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189567_bb0070","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbcan.2007.11.001","article-title":"Proteases as modulators of tumor\u2013stromal interaction: primary tumors to bone metastases","volume":"1785","author":"Wilson","year":"2008","journal-title":"Biochimica et Biophysica Acta (BBA) Rev. Cancer"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189567_bb0075","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0955-0674(00)00248-9","article-title":"Matrix metalloproteinases: they\u2019re not just for matrix anymore!","volume":"13","author":"McCawley","year":"2001","journal-title":"Curr. Opin. Cell Biol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189567_bb0080","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1357-4310(00)01686-5","article-title":"Matrix metalloproteinases: multifunctional contributors to tumor progression","volume":"6","author":"McCawley","year":"2000","journal-title":"Mol. Med. Today"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189567_bb0085","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.70265","article-title":"Overview of MMP biology and gene associations in human diseases","volume":"20","author":"Djuric","year":"2017","journal-title":"Role Matrix Metalloproteinase Hum. Body Pathol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189567_bb0090","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1601-0825.1996.tb00206.x","article-title":"Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation","volume":"2","author":"Reynolds","year":"1996","journal-title":"Oral Dis."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189567_bb0095","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbamcr.2010.01.003","article-title":"The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity","volume":"1803","author":"Brew","year":"2010","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Cell Res."},{"key":"10.1016\/j.bbcan.2026.189567_bb0100","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1023\/A:1025051214001","article-title":"Role of matrix metalloproteinases and their inhibitors in tumor invasion and metastasis","volume":"68","author":"Khasigov","year":"2003","journal-title":"Biochem. Mosc."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189567_bb0105","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbapap.2011.10.002","article-title":"Cysteine cathepsins: from structure, function and regulation to new frontiers","volume":"1824","author":"Turk","year":"2012","journal-title":"Biochim. Biophy. Acta Proteins Proteomics"},{"key":"10.1016\/j.bbcan.2026.189567_bb0110","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.biopha.2018.05.148","article-title":"Cathepsins: proteases that are vital for survival but can also be fatal","volume":"105","author":"Patel","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189567_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107347","article-title":"Extracellular proteolysis in cancer: proteases, substrates, and mechanisms in tumor progression and metastasis","volume":"300","author":"Radisky","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2026.189567_bb0120","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.matbio.2024.10.007","article-title":"Remodeling of the extracellular matrix by serine proteases as a prerequisite for cancer initiation and progression","volume":"134","author":"Wenta","year":"2024","journal-title":"Matrix Biol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189567_bb0125","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/10408363.2016.1154643","article-title":"Kallikrein-related peptidases (KLKs) and the hallmarks of cancer","volume":"53","author":"Filippou","year":"2016","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.bbcan.2026.189567_bb0130","first-page":"163","article-title":"New functions for the matrix metalloproteinases in cancer progression","volume":"2","author":"Egeblad","year":"2001","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189567_bb0135","doi-asserted-by":"crossref","first-page":"1108695","DOI":"10.3389\/fonc.2022.1108695","article-title":"Matrix metalloproteinases as therapeutic targets in breast cancer","volume":"12","author":"Kwon","year":"2023","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189567_bb0140","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1083\/jcb.139.7.1861","article-title":"Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells","volume":"139","author":"Lochter","year":"1997","journal-title":"J. Cell Biol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189567_bb0145","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0092-8674(00)81009-0","article-title":"The stromal proteinase MMP3\/stromelysin-1 promotes mammary carcinogenesis","volume":"98","author":"Sternlicht","year":"1999","journal-title":"Cell"},{"issue":"7047","key":"10.1016\/j.bbcan.2026.189567_bb0150","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature03688","article-title":"Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability","volume":"436","author":"Radisky","year":"2005","journal-title":"Nature"},{"issue":"11\u221212","key":"10.1016\/j.bbcan.2026.189567_bb0155","doi-asserted-by":"crossref","first-page":"480","DOI":"10.18632\/genesandcancer.90","article-title":"Tumor cell expression of MMP3 as a prognostic factor for poor survival in pancreatic, pulmonary, and mammary carcinoma","volume":"6","author":"Mehner","year":"2015","journal-title":"Genes Cancer"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189567_bb0160","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3390\/jcm10071436","article-title":"Plasma concentrations of matrilysins MMP-7 and MMP-26 as diagnostic biomarkers in breast cancer","volume":"10","author":"Piskor","year":"2021","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189567_bb0165","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.bbrc.2005.06.010","article-title":"Matrix metalloproteinase-7 degrades all insulin-like growth factor binding proteins and facilitates insulin-like growth factor bioavailability","volume":"333","author":"Nakamura","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5547","key":"10.1016\/j.bbcan.2026.189567_bb0170","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1126\/science.1064829","article-title":"Taking cell-matrix adhesions to the third dimension","volume":"294","author":"Cukierman","year":"2001","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189567_bb0175","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0092-8674(03)00513-0","article-title":"Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix","volume":"114","author":"Hotary","year":"2003","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.bbcan.2026.189567_bb0180","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.3390\/cells12172187","article-title":"MT1-MMP as a key regulator of metastasis","volume":"12","author":"Tanaka","year":"2023","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189567_bb0185","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1073\/pnas.97.8.3884","article-title":"Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model","volume":"97","author":"Fang","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189567_bb0190","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1101\/gad.1407406","article-title":"Distinct roles for cysteine cathepsin genes in multistage tumorigenesis","volume":"20","author":"Gocheva","year":"2006","journal-title":"Genes Dev."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189567_bb0195","doi-asserted-by":"crossref","first-page":"R217","DOI":"10.1186\/bcr651","article-title":"E-cadherin expression in primary carcinomas of the breast and its distant metastases","volume":"5","author":"Kowalski","year":"2003","journal-title":"Breast Cancer Res."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189567_bb0200","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1074\/mcp.M114.044628","article-title":"Proteomic identification of cysteine cathepsin substrates shed from the surface of cancer cells","volume":"14","author":"Soboti\u010d","year":"2015","journal-title":"Mol. Cell. Proteomics"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189567_bb0205","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1038\/s41467-020-18935-2","article-title":"Cathepsin D deficiency in mammary epithelium transiently stalls breast cancer by interference with mTORC1 signaling","volume":"11","author":"Ketterer","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189567_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13058-020-01376-6","article-title":"Cathepsin V suppresses GATA3 protein expression in luminal A breast cancer","volume":"22","author":"Sereesongsaeng","year":"2020","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189567_bb0215","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2004.06.010","article-title":"Molecular characterization of the tumor microenvironment in breast cancer","volume":"6","author":"Allinen","year":"2004","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189567_bb0220","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ccr.2008.01.011","article-title":"GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model","volume":"13","author":"Kouros-Mehr","year":"2008","journal-title":"Cancer Cell"},{"issue":"25","key":"10.1016\/j.bbcan.2026.189567_bb0225","doi-asserted-by":"crossref","first-page":"15758","DOI":"10.1074\/jbc.M114.624353","article-title":"Stress-resistant translation of cathepsin L mRNA in breast cancer progression","volume":"290","author":"Tholen","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189567_bb0230","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4149\/neo_2016_004","article-title":"Cathepsin L is involved in proliferation and invasion of breast cancer cells","volume":"63","author":"Qin","year":"2016","journal-title":"Neoplasma"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189567_bb0235","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/s41419-022-05215-8","article-title":"Cathepsin K regulates the tumor growth and metastasis by IL-17\/CTSK\/EMT axis and mediates M2 macrophage polarization in castration-resistant prostate cancer","volume":"13","author":"Wu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189567_bb0240","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10549-004-2624-x","article-title":"Tissue-type plasminogen activator (tPA) in breast cancer: relationship with clinicopathological parameters and prognostic significance","volume":"90","author":"Corte","year":"2005","journal-title":"Breast Cancer Res. Treat."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189567_bb0245","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.cell.2009.02.018","article-title":"Platelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic ligand site","volume":"137","author":"Trivedi","year":"2009","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189567_bb0250","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cell.2004.12.018","article-title":"PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells","volume":"120","author":"Boire","year":"2005","journal-title":"Cell"},{"issue":"63","key":"10.1016\/j.bbcan.2026.189567_bb0255","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.21015","article-title":"Protease-activated receptor-1 (PAR-1): a promising molecular target for cancer","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189567_bb0260","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s42003-022-03642-z","article-title":"Invadopodia enable cooperative invasion and metastasis of breast cancer cells","volume":"5","author":"Perrin","year":"2022","journal-title":"Commun. Biol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189567_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121003","article-title":"The invadopodia scaffold protein Tks5 is required for the growth of human breast cancer cells in vitro and in vivo","volume":"10","author":"Blouw","year":"2015","journal-title":"PLoS One"},{"issue":"41","key":"10.1016\/j.bbcan.2026.189567_bb0270","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1038\/sj.onc.1209572","article-title":"Furin regulates the intracellular activation and the uptake rate of cell surface-associated MT1-MMP","volume":"25","author":"Remacle","year":"2006","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189567_bb0275","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1158\/0008-5472.CAN-05-2177","article-title":"Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function","volume":"66","author":"Artym","year":"2006","journal-title":"Cancer Res."},{"issue":"2A","key":"10.1016\/j.bbcan.2026.189567_bb0280","first-page":"973","article-title":"Quantitative immunohistochemical and in situ hybridization analysis of metalloproteinases in prostate cancer","volume":"26","author":"Cardillo","year":"2006","journal-title":"Anticancer Res."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189567_bb0285","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jare.2016.06.007","article-title":"Hormonal-receptor positive breast cancer: IL-6 augments invasion and lymph node metastasis via stimulating cathepsin B expression","volume":"7","author":"Ibrahim","year":"2016","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.bbcan.2026.189567_bb0290","doi-asserted-by":"crossref","DOI":"10.4137\/CGM.S27335","article-title":"New insight on the role of plasminogen receptor in cancer progression","volume":"8","author":"Kumari","year":"2015","journal-title":"Cancer Growth Metastasis"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189567_bb0295","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.3390\/cancers13081838","article-title":"Plasmin and plasminogen system in the tumor microenvironment: implications for cancer diagnosis, prognosis, and therapy","volume":"13","author":"Bharadwaj","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189567_bb0300","first-page":"269","article-title":"Kallikrein-related peptidases in prostate cancer: from molecular function to clinical application","volume":"25","author":"Fuhrman-Luck","year":"2014","journal-title":"Ejifcc"},{"issue":"17","key":"10.1016\/j.bbcan.2026.189567_bb0305","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.3390\/ijms21175983","article-title":"Roles of proteoglycans and glycosaminoglycans in cancer development and progression","volume":"21","author":"Wei","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189567_bb0310","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1111\/febs.12198","article-title":"Functional interactions between matrix metalloproteinases and glycosaminoglycans","volume":"280","author":"Tocchi","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.bbcan.2026.189567_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-014-0279-8","article-title":"Cell surface heparan sulfate proteoglycans control adhesion and invasion of breast carcinoma cells","volume":"14","author":"Lim","year":"2015","journal-title":"Mol. Cancer"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189567_bb0320","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.bbamcr.2017.05.027","article-title":"Metalloproteinases in extracellular vesicles","volume":"1864","author":"Shimoda","year":"2017","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Cell Res."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189567_bb0325","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1093\/jnci\/djq153","article-title":"Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis","volume":"102","author":"Hendrix","year":"2010","journal-title":"JNCI J. Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189567_bb0330","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/sj.onc.1207070","article-title":"The microvesicle as a vehicle for EMMPRIN in tumor\u2013stromal interactions","volume":"23","author":"Sidhu","year":"2004","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189567_bb0335","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.tibs.2019.06.007","article-title":"Dynamic interplay between miRNAs and the extracellular matrix influences the tumor microenvironment","volume":"44","author":"Piperigkou","year":"2019","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbcan.2026.189567_bb0340","article-title":"miR-200b restrains EMT and aggressiveness and regulates matrix composition depending on ER status and signaling in mammary cancer","volume":"6","author":"Piperigkou","year":"2020","journal-title":"Matrix Biol. Plus"},{"key":"10.1016\/j.bbcan.2026.189567_bb0345","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.matbio.2017.08.002","article-title":"Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer","volume":"64","author":"Piperigkou","year":"2017","journal-title":"Matrix Biol."},{"key":"10.1016\/j.bbcan.2026.189567_bb0350","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.critrevonc.2019.02.010","article-title":"Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer","volume":"137","author":"Gonzalez-Avila","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbcan.2026.189567_bb0355","doi-asserted-by":"crossref","unstructured":"J.B. Wyckoff, Y. Wang, E.Y. Lin, J.-f. Li, S. Goswami, E.R. Stanley, J.E. Segall, J.W. Pollard, J. Condeelis, Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors, Cancer Res. 67(6) (2007) 2649\u20132656.","DOI":"10.1158\/0008-5472.CAN-06-1823"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189567_bb0360","first-page":"2347","article-title":"Breast tumor cells transendothelial migration induces endothelial cell anoikis through extracellular matrix degradation","volume":"29","author":"Peyri","year":"2009","journal-title":"Anticancer Res."},{"issue":"9b","key":"10.1016\/j.bbcan.2026.189567_bb0365","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1111\/j.1582-4934.2009.00764.x","article-title":"Membrane-type 4 matrix metalloproteinase (MT4-MMP) induces lung metastasis by alteration of primary breast tumour vascular architecture","volume":"13","author":"Chabottaux","year":"2009","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189567_bb0370","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)81478-6","article-title":"Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay","volume":"94","author":"Kim","year":"1998","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189567_bb0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2003-0025","article-title":"Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response","volume":"26","author":"Steinhoff","year":"2005","journal-title":"Endocr. Rev."},{"issue":"23","key":"10.1016\/j.bbcan.2026.189567_bb0380","doi-asserted-by":"crossref","first-page":"8613","DOI":"10.1158\/0008-5472.CAN-04-2078","article-title":"Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation","volume":"64","author":"Im","year":"2004","journal-title":"Cancer Res."},{"issue":"15","key":"10.1016\/j.bbcan.2026.189567_bb0385","doi-asserted-by":"crossref","first-page":"7766","DOI":"10.1158\/0008-5472.CAN-05-3897","article-title":"Tumor-derived matrix metalloproteinase-1 targets endothelial proteinase-activated receptor 1 promoting endothelial cell activation","volume":"66","author":"Goerge","year":"2006","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189567_bb0390","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.thromres.2007.06.002","article-title":"Role of metalloproteinases in platelet function","volume":"121","author":"Santos-Mart\u00ednez","year":"2008","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189567_bb0395","first-page":"237","article-title":"A novel role of metalloproteinase in cancer-mediated immunosuppression","volume":"61","author":"Sheu","year":"2001","journal-title":"Cancer Res."},{"issue":"6\u20137","key":"10.1016\/j.bbcan.2026.189567_bb0400","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.biocel.2007.11.026","article-title":"The role of proteases in transforming growth factor-\u03b2 activation","volume":"40","author":"Jenkins","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"15","key":"10.1016\/j.bbcan.2026.189567_bb0405","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1158\/0008-5472.CAN-13-0305","article-title":"Myeloid-derived suppressor cells as osteoclast progenitors: a novel target for controlling osteolytic bone metastasis","volume":"73","author":"Sawant","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189567_bb0410","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10555-006-9036-9","article-title":"Bone marrow cells in the \u2018pre-metastatic niche\u2019: within bone and beyond","volume":"25","author":"Kaplan","year":"2006","journal-title":"Cancer Metastasis Rev."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189567_bb0415","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.bone.2006.09.016","article-title":"Inhibition of bone resorption, rather than direct cytotoxicity, mediates the anti-tumour actions of ibandronate and osteoprotegerin in a murine model of breast cancer bone metastasis","volume":"40","author":"Zheng","year":"2007","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189567_bb0420","first-page":"1","article-title":"Molecular mechanism and potential targets for bone metastasis, Gan to Kagaku ryoho","volume":"34","author":"Iguchi","year":"2007","journal-title":"Cancer Chemother."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189567_bb0425","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s12276-024-01163-9","article-title":"Cathepsin D promotes polarization of tumor-associated macrophages and metastasis through TGFBI-CCL20 signaling","volume":"56","author":"Lee","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189567_bb0430","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1101\/gad.1874010","article-title":"IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion","volume":"24","author":"Gocheva","year":"2010","journal-title":"Genes Dev."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189567_bb0435","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/onc.2012.166","article-title":"Macrophage cathepsin K promotes prostate tumor progression in bone","volume":"32","author":"Herroon","year":"2013","journal-title":"Oncogene"},{"issue":"19","key":"10.1016\/j.bbcan.2026.189567_bb0440","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1158\/0008-5472.CAN-20-3251","article-title":"The CD200\u2013CD200R axis promotes squamous cell carcinoma metastasis via regulation of cathepsin K","volume":"81","author":"Khan","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189567_bb0445","series-title":"Seminars in Cancer Biology","first-page":"99","article-title":"Metastatic colonization: settlement, adaptation and propagation of tumor cells in a foreign tissue environment","author":"Shibue","year":"2011"},{"issue":"7069","key":"10.1016\/j.bbcan.2026.189567_bb0450","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nature04186","article-title":"VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche","volume":"438","author":"Kaplan","year":"2005","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189567_bb0455","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1677\/erc.0.0110207","article-title":"The role of bisphosphonates in breast and prostate cancers","volume":"11","author":"Brown","year":"2004","journal-title":"Endocr. Relat. Cancer"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189567_bb0460","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1172\/JCI119435","article-title":"Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2","volume":"99","author":"Yoneda","year":"1997","journal-title":"J. Clin. Invest."},{"issue":"5146","key":"10.1016\/j.bbcan.2026.189567_bb0465","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1126\/science.8290962","article-title":"Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells","volume":"263","author":"Zou","year":"1994","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.bbcan.2026.189567_bb0470","doi-asserted-by":"crossref","first-page":"11669","DOI":"10.1073\/pnas.93.21.11669","article-title":"Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells","volume":"93","author":"Sheng","year":"1996","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"13","key":"10.1016\/j.bbcan.2026.189567_bb0475","doi-asserted-by":"crossref","first-page":"7847","DOI":"10.1073\/pnas.1331360100","article-title":"Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis","volume":"100","author":"Cher","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189567_bb0480","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0002-9440(10)62337-1","article-title":"Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue","volume":"166","author":"Dong","year":"2005","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189567_bb0485","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jnci\/94.1.17","article-title":"Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis","volume":"94","author":"Nemeth","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"issue":"17","key":"10.1016\/j.bbcan.2026.189567_bb0490","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.lfs.2006.05.024","article-title":"MMP-9 antisense oligodeoxynucleotide exerts an inhibitory effect on osteoclastic bone resorption by suppressing cell migration","volume":"79","author":"Ishibashi","year":"2006","journal-title":"Life Sci."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189567_bb0495","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1158\/0008-5472.CAN-06-1210","article-title":"Monocyte chemotactic protein-1 mediates prostate cancer\u2013induced bone resorption","volume":"67","author":"Lu","year":"2007","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189567_bb0500","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ccr.2005.04.013","article-title":"MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL","volume":"7","author":"Lynch","year":"2005","journal-title":"Cancer Cell"},{"issue":"16","key":"10.1016\/j.bbcan.2026.189567_bb0505","doi-asserted-by":"crossref","first-page":"6747","DOI":"10.1158\/0008-5472.CAN-08-3949","article-title":"Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis","volume":"69","author":"Thiolloy","year":"2009","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189567_bb0510","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/mc.1067","article-title":"Inhibition of osteoclast differentiation and bone resorption by cathepsin K antisense oligonucleotides","volume":"32","author":"Ishikawa","year":"2001","journal-title":"Mol. Carcinog."},{"issue":"21","key":"10.1016\/j.bbcan.2026.189567_bb0515","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1093\/nar\/29.21.4361","article-title":"IL-1 induces collagenase-3 (MMP-13) promoter activity in stably transfected chondrocytic cells: requirement for Runx-2 and activation by p38 MAPK and JNK pathways","volume":"29","author":"Mengshol","year":"2001","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189567_bb0520","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.pcan.4500387","article-title":"Cell adhesion and chemotaxis in prostate cancer metastasis to bone: a minireview","volume":"3","author":"Cooper","year":"2000","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189567_bb0525","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.bbrc.2004.11.070","article-title":"Crosstalk between cancer cells and bone microenvironment in bone metastasis","volume":"328","author":"Yoneda","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189567_bb0530","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1101\/gad.14.2.163","article-title":"Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-\u03b2 and promotes tumor invasion and angiogenesis","volume":"14","author":"Yu","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2026.189567_bb0535","doi-asserted-by":"crossref","first-page":"2028S","DOI":"10.1093\/jn\/125.suppl_7.2028S","article-title":"Endothelin receptors, second messengers, and actions in bone","volume":"125","author":"Stern","year":"1995","journal-title":"J. Nutr."},{"issue":"S3","key":"10.1016\/j.bbcan.2026.189567_bb0540","first-page":"779","article-title":"Role of endothelin-1 in osteoblastic bone metastases","volume":"97","author":"Guise","year":"2003","journal-title":"Cancer Interdiscip. Int. J. Am. Cancer Soc."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189567_bb0545","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1054\/bjoc.2000.1261","article-title":"Endothelin-1 from prostate cancer cells is enhanced by bone contact which blocks osteoclastic bone resorption","volume":"83","author":"Chiao","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189567_bb0550","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1007\/s00432-019-02950-y","article-title":"Targeting cathepsin K diminishes prostate cancer establishment and growth in murine bone","volume":"145","author":"Liang","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189567_bb0555","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1158\/0008-5472.CAN-08-1956","article-title":"Cathepsin G recruits osteoclast precursors via proteolytic activation of protease-activated receptor-1","volume":"69","author":"Wilson","year":"2009","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189567_bb0560","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/MOH.0b013e3280dce568","article-title":"Protease-activated receptor signaling: new roles and regulatory mechanisms","volume":"14","author":"Traynelis","year":"2007","journal-title":"Curr. Opin. Hematol."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189567_bb0565","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1158\/1541-7786.MCR-09-0028","article-title":"Cathepsin G\u2013mediated activation of pro\u2013matrix metalloproteinase 9 at the tumor-bone Interface promotes transforming growth factor-\u03b2 signaling and bone destruction","volume":"7","author":"Wilson","year":"2009","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189567_bb0570","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.biopha.2016.12.021","article-title":"Role of protease and protease inhibitors in cancer pathogenesis and treatment","volume":"86","author":"Eatemadi","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189567_bb0575","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/targets3010008","article-title":"From bench to bedside: transforming cancer therapy with protease inhibitors","volume":"3","author":"Shoari","year":"2025","journal-title":"Targets"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189567_bb0580","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3390\/cells9051313","article-title":"Metalloproteinases and their inhibitors: potential for the development of new therapeutics","volume":"9","author":"Raeeszadeh-Sarmazdeh","year":"2020","journal-title":"Cells"},{"issue":"23","key":"10.1016\/j.bbcan.2026.189567_bb0585","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1200\/JCO.2004.08.054","article-title":"Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196","volume":"22","author":"Sparano","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189567_bb0590","doi-asserted-by":"crossref","first-page":"1445025","DOI":"10.3389\/fonc.2024.1445025","article-title":"The emerging role of osteoclasts in the treatment of bone metastases: rationale and recent clinical evidence","volume":"14","author":"Liu","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189567_bb0595","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/DDDT.S285852","article-title":"Current status and perspectives of protease inhibitors and their combination with nanosized drug delivery systems for targeted cancer therapy","author":"Rudzi\u0144ska","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189567_bb0600","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3390\/catal14110787","article-title":"Advancements in serine protease inhibitors: from mechanistic insights to clinical applications","volume":"14","author":"Wei","year":"2024","journal-title":"Catalysts"},{"key":"10.1016\/j.bbcan.2026.189567_bb0605","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.trecan.2025.02.004","article-title":"Protease regulation of tumor-immune cell symbiosis","volume":"11","author":"Pang","year":"2025","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189567_bb0610","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13058-020-01376-6","article-title":"Cathepsin V suppresses GATA3 protein expression in luminal A breast cancer","volume":"22","author":"Sereesongsaeng","year":"2020","journal-title":"Breast Cancer Res."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189567_bb0615","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s11307-024-01955-5","article-title":"Immunohistochemical evaluation of cathepsin B, L, and S expression in breast cancer patients","volume":"26","author":"Linders","year":"2024","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.bbcan.2026.189567_bb0620","doi-asserted-by":"crossref","first-page":"1302587","DOI":"10.3389\/fimmu.2024.1302587","article-title":"Cellular interactions in tumor microenvironment during breast cancer progression: new frontiers and implications for novel therapeutics","volume":"15","author":"Akinsipe","year":"2024","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189567_bb0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105614","article-title":"New insight into the agonism of protease-activated receptors as an immunotherapeutic strategy","volume":"300","author":"Jiang","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2026.189567_bb0630","doi-asserted-by":"crossref","first-page":"13922","DOI":"10.3389\/abp.2025.13922","article-title":"Advancements in single-cell RNA sequencing and spatial transcriptomics: transforming biomedical research","volume":"72","author":"Molla Desta","year":"2025","journal-title":"Acta Biochim. Pol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189567_bb0635","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1021\/acs.jmedchem.0c01640","article-title":"Proteases and their modulators in cancer therapy: challenges and opportunities","volume":"64","author":"Song","year":"2021","journal-title":"J. Med. Chem."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26000399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26000399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T08:34:45Z","timestamp":1782030885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26000399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":127,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0304419X26000399"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189567","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutting to the core: Proteases in the tumor\u2013bone interface and metastatic progression","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189567","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189567"}}